2017 Graft versus Host Disease Symposium

ABOUT THE GvHD NATIONAL SYMPOSIUM 

This unique conference, which focuses on cutting edge research and new treatments, consists of two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers.

The Meredith A. Cowden Foundation in collaboration with the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, and Cleveland Clinic Taussig Cancer Institute, created the National GvHD Health Symposium in 2010 to raise awareness about Graft vs. Host Disease (GvHD), to promote research to further our understanding of its cause, and to review cutting edge approaches to prevention and treatment.

Over 1,200 people have attended this event, which provides an opportunity for attendees to interact with some of the world’s leading authorities on GvHD, a complication that affects over 60% of bone marrow transplant patients.

This year we are excited to team up with the The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, who will serve as hosts of the 2017 symposium!

We hope to see you there!